U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [ ] Check box if no longer subject of Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Giles David K (Last) (First) (Middle) 714 East 7200 South (Street) Midvale Utah 84047 (City) (State) (Zip) -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Wasatch Pharmaceutical, Inc. (WASP) -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) -------------------------------------------------------------------------------- 4. Statement for Month/Year July 2000 -------------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Year) -------------------------------------------------------------------------------- 6. Relationship of Reporting Person to Issuer (Check all applicable) [ ] Director [ ] 10% Owner [X] Officer (give title below) [ ] Other (specify below) Chief Financial Officer -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) [X] Form filed by one Reporting Person [ ] Form filed by more than one Reporting Person --------------------------------------------------------------------------------

Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security 2.Trans- 3.Trans- 4.Securities Acquired (A) 5.Amount of 6.Owner- 7.Nature of (Instr.3) action action or Disposed of (D) Securities ship Indirect Date Code (Instr. 3, 4 and 5) Beneficially Form: Beneficial (Month/ (Instr. ------------------------- Owned at Direct Ownership Day/Year) 8) A End of (D) or (Instr. 4) Amount or Price Issuer's Indirect D Fiscal Year (I) (Instr. 3 & 4) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 047/0617/00 SG ~~200~~5,000 A(D) ~~$.001~~gift ~~745~~Common Stock 7/17/00 G 5,~~455~~000 (D) gift Common Stock 7/17/00 G 2,500 (D) gift Common Stock 7/17/00 G 50,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 10,000 (D) gift Common stock 7/17/00 G 10,000 (D) gift Common Stock 7/17/00 G 5,000 (D) gift Common Stock 7/17/00 G 5,000 (D) gift Common Stock 7/17/00 G 5,000 (D) gift Common Stock (1) 7/17/00 G 5,000 (D) gift 1,443,200 (D) 55,800 (I) ------------------------------------------------------------------------------------------------------------------------------------ * If the Form is filed by more than one reporting person, see instruction 4(b)(v). Reminder: Report on a separate line for eavh class of securities beneficially owned directly or indirectly. FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ------------------------------------------------------------------------------------------------------------------------------------ 1.Title of 2.Conver- 3.Trans- 4.Trans- 5.Number of 6.Date Exer- 7.Title and 8.Price 9.Number 10.Owner- 11.Nature Derivative sion or action action Derivative cisable and Amount of of of Deri- ship of of In- Security Exercise Date Code Securities Expiration Underlying Deri- vative Deriva- direct (Instr. 3) Price of (Month/ (Instr. Acquired Date (Month/ Securities vative Secur- tive Bene- Deri- Day/ 8) (A) or Day/Year) (Instr. 3 Secu- ities Security: ficial vative Year) Disposed and 4) rity Benefi- Direct Owner- Security of (D) ----------------------------- (Instr. cially (D) or ship (Instr.3, Date Expir- Amount or 5) Owned Indirect (Instr. 4, and 5) Exer- ation Title Number of at End (I) 4) ----------- cisable Date Shares of Year (Instr.4) (A) (D) (Instr.4) ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: 1. ~~Exercise~~gifts ofto ~~stock~~children ~~options~~and ~~from 1999~~relatives. 2.Final ~~The number of~~ shares ~~represented by the exercise of stock option shares~~ are ~~pre-~~post split shares ~~not~~after ~~taking into account~~ the 1:2 reverse split effective June 22, 2000. ** Intentional misstatements or omissions of facts constitute /s/ ~~Craig~~David ~~Heesch~~K. ~~08/~~Giles 11/14/00 Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). -------------------------------- -------- ** Signature of Reporting Person Date Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.

Filing Compare · WASATCH PHARMACEUTICAL INC